As Covid-19 vaccine candidates make their way through the clinical trial process, we investigate what can be done to counter the growing number of antivaxxers that oppose a pharmaceutical intervention. Plus, we take a look at the rising number of gout diagnosis and what pharma is doing to tackle this surge.
Also, we examine innovative ways to treat chronic pain without painkillers, find out what is being done to fix a lack of equal representation of Black, Latinx and Native American people in Covid-19 drug trials, and learn about Genoskin’s unusual alternative to animal testing that uses human skin models collected after plastic surgery procedures.
Plus, we take a look at a new breast cancer ‘ecosystem’ that contains promising new therapeutic targets for the pharma industry, speak to Atomwise about the company’s drug discovery platform AtomNet, and explore the potential of quantum computing in life sciences.
Editor | Eloise McLennan
Group Editor | Susanne Hauner
Commissioning Editor | Daniel Garrun
Writers | Allie Nawrat, Chris Lo, Abi Millar, Chloe Kent, Peter Kohut
Magazine Designer | Marzia Del Gaone
Graphic Designers | Filipe Costa, Anett Arc, Ashley McPherson, Tyrrell Lowe, Noemi Balint, Petra Konyi-Kiss, Maria Gimenez, Martina Labaiova
Lead Designer | John Hammond
Digital Publishing Director | Duncan West
Sales Manager | Nimai Amin
+44 (0) 207 936 6453
For media partnership enquiries please contact: Susanne Hauner
Pharma Technology focus is powered by h5mag
read past issues of pharma technology focus HERE
Copyright 2020 NRi Digital, a trading division of Verdict Media Ltd. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.